Some of our cancer centers are experiencing issues.  View More Important Notifications x
texas oncology more breakthroughs. more victories



Texas Oncology Celebrates Nurses, Encourages Others to Say #SuperThanks

DALLAS — Texas Oncology is celebrating the invaluable role nurses and other healthcare professionals play in treating patients with cancer and other serious illnesses as part of an annual Thanksgiving program recognizing those who are on the front lines with patients and families every day. They are nothing short of super heroes.

Texas Oncology physicians invite others to join the community-based practice in saying #SuperThanks to the more than three and a half million registered nurses and licensed practical nurses in the United States. Nurses and healthcare teams may care for a patient for a short time, but the impact can last a lifetime.

“Nurses are nothing short of super heroes, expertly blending and balancing compassion with expertise,” said Dr. Steve Paulson, Texas Oncology chairman and president. “Recent events have highlighted how indispensable nurses are to the healthcare team. They often put patient needs ahead of their own, and they deserve our sincere thanks and admiration.”

To recognize your favorite nurse or healthcare professional:

“This year, more than 119,000 Texans will be diagnosed with cancer. While their treatment plans will be as diverse as our state, all will have nurse super heroes watching out for them,” said Paulson. “We are challenging others to join us in saying #SuperThanks.”

About Texas Oncology

Texas Oncology is an independent private practice with more than 490 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 90 FDA-approved therapies, about one-third of all cancer therapies approved to date. For more information, visit